In Situ is a healthcare technology-based startup which uses cell therapy as a tool for the creation of innovative products.
We currently have three products in the R&D phase: the 3D biodressing containing stem cells to treat chronic wounds and severe burns , the topical formulation containing extracellular nanovesicles for the treatment of less complex wounds and scars, and the 3D biograft intended for the treatment of gingival recession.
With a lot of technology and empathy, our focus is the generation of value for the treatment of our patients, which undoubtedly culminates in the improvement of the quality of life.
CRYOPRESERVED CELLS
Laboratory Cultivation
3D printing of biocuratives
Local application of biocuratives
3D printing biodressing containing stem-cells
PROBLEM / OPPORTUNIT
Chronic wounds and severe burns are linked with: Pain, infection, amputations, hospitalization and death Treating such illness involve high costs to: Patients / Public health system
HOW WE CAN SOLVE IT
We use 3D bioprinting to create biodressing containing stem cells. Biodressing are applied onto the wounds / burns. Non-invasive and highly efficient way of treating these wounds
OUR COMPETITIVE ADVANTAGE
We do not have any direct competitors, we are working exactly where most have failed. Similar technology is found outside
Brazil but using different cell types. Most of the biodressings only temporarily cover the wound area: Less durable / Less effective / Much higher costs
SUPPORT AND PARTNERS
OUR TEAM
We are formats by a team composed of PhD and masters in science and finance. Our scientific council is made up of university professors